Keyphrases
Major Pulmonary Resection
75%
Non-small Cell Lung Cancer (NSCLC)
75%
Israeli
62%
COVID-19
50%
Non-intubated
50%
Robotics
50%
Hospital Stay
47%
Lung
43%
Video-assisted Thoracoscopic Surgery
37%
Thoracoscopic
35%
Parathyroidectomy
33%
Postoperative Complications
32%
Exosomes
31%
Parathyroid Lesions
30%
Medical Center
28%
Thoracotomy
28%
Surgical Procedures
26%
Lipoma
25%
Conventional Treatment
25%
Intrathoracic Goiter
25%
Cluster of Differentiation 24
25%
Treatment Methods
25%
Lung Volume Reduction
25%
Thyroid Incidentaloma
25%
Lung Volume Reduction Surgery
25%
Jehovah's Witness Patients
25%
Neoadjuvant Chemoradiotherapy (nCRT)
25%
Immune Regulation
25%
NIVATS
25%
EXO-CD24
25%
Neoadjuvant Chemotherapy
25%
Minimalist
25%
Surgical Approach
25%
Intentional Replantation
25%
Clinical Anesthesia
25%
Respiratory Disease
25%
Potentially Resectable
25%
Rhombencephalitis
25%
Last Resort
25%
Goiter
25%
Low Radiation
25%
Kelch-like
25%
Hyperactivity
25%
Single-photon Emission Computed Tomography (SPECT)
25%
Mediastinal Surgery
25%
Prolonged Air Leak
25%
Thymic Neoplasms
25%
Technetium Tc 99m Sestamibi
25%
Thoracoscopic Bullectomy
25%
Bilateral Hearing Loss
25%
Medicine and Dentistry
Pneumonectomy
100%
Non Small Cell Lung Cancer
75%
Surgery
57%
Thymectomy
50%
Parathyroid
50%
Video-Assisted Thoracoscopic Surgery
44%
Thoracotomy
39%
Parathyroidectomy
33%
Neoplasm
33%
Morbidity
31%
Surgical Approach
31%
Postoperative Complication
30%
Surgical Technique
28%
Recurrent Disease
27%
Dyspnea
26%
Bleeding
25%
Cross Sectional Study
25%
Thyroid Incidentaloma
25%
Retrosternal Goiter
25%
COVID-19
25%
Spontaneous Pneumothorax
25%
Infarction
25%
Chemoradiotherapy
25%
Biopsy
25%
Cancer Screening
25%
Malignant Neoplasm
25%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
25%
Single Photon Emission Computed Tomography-Computed Tomography
25%
Goiter
25%
Neoadjuvant Chemotherapy
25%
Bilateral Hearing Loss
25%
Lung Volume
25%
Technetium-99
25%
Lipoblastoma
25%
Replantation
25%
Interstitial Lung Disease
25%
Anesthesia Complication
25%
Seminoma
25%
Operation Duration
23%
Diagnosis
21%
Symptom
21%
Myasthenia gravis
18%
Mediastinal Tumor
16%
Parathyroid Scintiscanning
16%
Recurrence Risk
16%
Thyroidectomy
16%
Median Sternotomy
15%
Mortality Rate
15%
Surgical Procedure
15%
Paraneoplastic Syndrome
15%